Synapse

← Heart Drug

Papers in Heart Drug

Page 2 · newest first

  1. Rate versus Rhythm Control – An Open and Shut Case?Heart Drug · 2003
  2. The Influence of Multiple Variables on the Prevalence of Aspirin Prescribing in Patients with Known Coronary Artery DiseaseHeart Drug · 2003
  3. Utility of the Combination of Echocardiography and Troponin T Test in Patients with ST Segment DepressionHeart Drug · 2002
  4. Left Ventricular Hypertrophy in HypertensionHeart Drug · 2002
  5. New Approaches to Treatment of Acute Myocardial Infarction: Combination Antiplatelet and Fibrinolytic TherapyHeart Drug · 2002
  6. Should Heart Failure Be Treated with Antithrombotic Drugs?Heart Drug · 2002
  7. Aggrenox® (Extended-Release Dipyridamole and Low-Dose Aspirin in Combination): Protecting Platelets from Excessive Activation in Patients with Vascular EventsHeart Drug · 2002
  8. Exercise-Induced ST Depression as a Prognostic Indicator of Cardiac Morbidity in Thrombolytic-Treated Post-Myocardial Infarction Patients with Silent IschemiaHeart Drug · 2002
  9. Cardiovascular Manifestations of Thyroid DiseaseHeart Drug · 2002
  10. n–3 Fatty Acids and Cardiovascular DiseaseHeart Drug · 2002
  11. Effect of Beta-Blockade on Heart Rate and VO₂ Kinetics during Recovery in Patients with Coronary Artery DiseaseHeart Drug · 2002
  12. Irbesartan in Primary Hypertension in Thai Patients: A Multicentre, Non-Comparative StudyHeart Drug · 2002
  13. Heart Failure in the Elderly: Characteristics of a Swedish Primary Health Care PopulationHeart Drug · 2002
  14. Is Heart Rate Reduction Beneficial to Patients with Chronic Congestive Heart Failure?Heart Drug · 2002
  15. Clopidogrel – Confounding or Confirming Our Concept of How to Treat Acute Coronary Syndromes?Heart Drug · 2002
  16. Economical Aspects of High-Sensitivity C-Reactive Protein as Predictor of Coronary Heart DiseaseHeart Drug · 2002
  17. Nesiritide: A Promising New Drug for the Treatment of Decompensated Heart FailureHeart Drug · 2002
  18. Cardiac Positron Emission TomographyHeart Drug · 2002
  19. Intravascular Ultrasound: Technique, Measurements and Angioplasty GuidanceHeart Drug · 2002
  20. The Frederiksberg Heart Failure Study: Rationale, Design and Methodology, with Special Emphasis on the Sampling Procedure for the Study Population and Its Comparison to the Background PopulationHeart Drug · 2002
  21. Logistics of Primary AngioplastyHeart Drug · 2002
  22. Warfarin: Mechanisms for Durable Effects in Coronary Artery DiseaseHeart Drug · 2002
  23. Acute Coronary Syndrome and Early Statin Therapy: What Is the Evidence?Heart Drug · 2002
  24. Prior Aspirin Therapy, Subsequent Stroke Severity and Mortality and Relationship with Cardiovascular Risk Factors in Patients Admitted to Hospital with Acute StrokeHeart Drug · 2002
  25. NF-κB as a Therapeutic Target for Cardiovascular DiseaseHeart Drug · 2002
  26. Reduction of QT Dispersion by Losartan in Patients with Mild to Moderate HypertensionHeart Drug · 2002
  27. Gold Standard Treatment of Carotid Stenosis: Carotid Surgery or Stent?Heart Drug · 2002
  28. Warfarin Therapy in Acute Coronary SyndromesHeart Drug · 2002
  29. EARTH: EndothelinA Receptor Antagonist Trial in Heart FailureHeart Drug · 2001
  30. Treatment of Atrial Fibrillation and Flutter: Focus on Oral Dofetilide, a New Selective Class III Antiarrhythmic AgentHeart Drug · 2001
  31. Effect of Beta-Blockade on Postexercise Oxygen Uptake Kinetics in Patients with Chronic Heart FailureHeart Drug · 2001
  32. Morbidity of Post-Coronary Artery Bypass Surgery Patients with Atrial Fibrillation Treated with Rate Control versus Sinus-Restoring TherapyHeart Drug · 2001
  33. Dependency on Infarct Size Limits the Clinical Applicability of Non-Invasive Reperfusion Assessment by Biochemical Markers in Acute Myocardial InfarctionHeart Drug · 2001
  34. Standardization of Central Off-Line Quantitative Image Analysis: Implications from Experiences with Quantitative Coronary AngiographyHeart Drug · 2001
  35. Biomarkers and Exercise Training: A Possible Missing Link between Physical Activity and Mortality Benefit in Patients with Heart FailureHeart Drug · 2001
  36. Vasopeptidase Inhibitors: A New Class of DrugsHeart Drug · 2001
  37. Transmyocardial Laser Revascularization: Established Procedure, Acupuncture of the Heart or Placebo Effect?Heart Drug · 2001
  38. Platelets and Thrombolysis: Cooperation or Contrariety?Heart Drug · 2001
  39. Variable Interindividual Responses to Antiplatelet Therapies – Do They Exist, Can We Measure Them, and Are They Clinically Relevant?Heart Drug · 2001
  40. Observations on the Use of Low-Dose Hydrochlorothiazide in the Treatment of Hypertension in Diabetic NigeriansHeart Drug · 2001
  41. Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial InfarctionHeart Drug · 2001
  42. Optimizing Reperfusion Therapy: Adjunct Use of Glycoprotein IIb/IIIa Antagonists with Fibrinolytic Therapy in Acute Myocardial InfarctionHeart Drug · 2001
  43. Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial InfarctionHeart Drug · 2001
  44. Surrogate End Points of Antihypertensive Treatment: Left Ventricular Hypertrophy and Structural Alteration of Carotid ArteriesHeart Drug · 2001
  45. Incidence of and Predicting Factors for Torsades de Pointes during Intravenous Administration of AmiodaroneHeart Drug · 2001
  46. Amiodarone: The Last and/or Best Hope for Pharmacological Control of Cardiac Arrhythmias?Heart Drug · 2001
  47. Neutral Peptidase InhibitorsHeart Drug · 2001
  48. Long-Term Treatment with Angiotensin-Converting Enzyme Inhibitors, Beta-Blockers or a Combination of Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers in Low-Risk Patients after Acute Myocardial Infarction: The ABC StudyHeart Drug · 2001
  49. Effect of ‘Drug Holiday’ on Blood Pressure Control: A Randomized Double-Blind Comparative Trial of Amlodipine versus Felodipine Extended Release in Chinese Patients with Mild to Moderate Essential HypertensionHeart Drug · 2001
  50. Glycoprotein IIb/IIIa Inhibitors in Acute Coronary SyndromesHeart Drug · 2001